News

July 17, 2019

Blood Test Ably Identifies Ovarian Cancer Prior to Surgery, Clinical Trial Planned

News

A blood test successfully identified ovarian cancer from circulating cells, and may enable this cancer to be detected early and prior to surgery, results of the first phase of ... Read more

July 15, 2019

Scientists Discover Enzyme with Key Role in Aggressive Ovarian Cancers

News

Scientists discovered a metabolic enzyme that adds methyl groups to other molecules, called nicotinamide N-methyltransferase, that plays an important role in the progression of high-grade serous carcinoma, the most ... Read more

July 12, 2019July 12, 2019

MDNA55-Interferons Combo Kills Cancer Cells, Extends Lifespan of Mice with Ovarian Cancer, Study Reports

News

Combining the experimental therapy MDNA55 with anti-cancer interferons (IFNs) can effectively kill cancer cells and extend the survival of mice with metastatic ovarian cancer, new research results show. The ... Read more

July 10, 2019

Zejula-Keytruda Trial Results Warrant Further Investigation for Recurrent OC

News

A combination of Zejula (niraparib) and Keytruda (pembrolizumab) is well-tolerated and has promising anti-tumor activity in women with ovarian carcinoma who have failed prior platinum-based chemotherapy, results from a ... Read more

July 8, 2019

Lynparza Approved in Japan as First-Line Maintenance Therapy for Advanced OC

News

Lynparza (olaparib) has been approved in Japan as a first-line maintenance treatment for women with BRCA-mutated advanced ovarian cancer that is responding, partially or completely, to their initial chemotherapy, AstraZeneca and Merck ... Read more

July 3, 2019

New Blood Test May Improve Ovarian Cancer Diagnosis, Study Suggests

News

A blood test that examines a panel of 11 specific proteins could help distinguish between benign tumors and malignant ovarian cancer, reducing the need for unnecessary surgeries and leading ... Read more

July 1, 2019

Testing for Multiple Biomarkers at a Time Can Increase Early Detection of OC

News

Testing for additional biomarkers along with the well-known biomarker CA125 can improve the detection of early-stage ovarian cancer, a new study shows. The blood-based assay could significantly improve patient ... Read more

June 28, 2019June 28, 2019

PARP Inhibitors Used in ‘One-two Punch’ Strategy to Kill OC Cells in Mouse Models, Study Shows

News

Researchers have developed a two-step approach that harnesses the aging process of cells, allowing breast and ovarian cancers to be effectively targeted and destroyed in cell and mouse preclinical ... Read more

June 26, 2019

FDA Grants Priority Review to GSK’s Zejula for Late Stage Ovarian Cancer

News

The U.S. Food and Drug Administration (FDA) has accepted the application of Tesaro, a GSK company, seeking to extend approval for Zejula (niraparib) to women with late stage ovarian ... Read more

June 24, 2019

Researchers Work to Create Screening Tool for Early or Pre-cancerous OC

News

Researchers from Clemson University and doctors from South Carolina’s Prisma Health-Upstate are collaborating to develop a screening tool that can identify ovarian cancer in its earlier stages, or even ... Read more

Pin It on Pinterest